Prunella vulgaris L. active components and their hypoglycemic and antinociceptive effects in alloxan-induced diabetic mice

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 1008-1018

  Raafat, K ^a   Wurglics, M ^b   Schubert Zsilavecz, M ^b  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alpha glucosidase; Diabetes mellitus; HbA1c; In vivo antioxidant; Painful diabetic neuropathy; Prunella vulgaris; Von frey filaments

Indexed keywords

ALPHA GLUCOSIDASE; AMYLASE; CAFFEIC ACID; CATALASE; COUMARIC ACID; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID PEROXIDE; PRUNELLA VULGARIS EXTRACT; ROSMARINIC ACID; ANALGESIC AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HBA(1C) PROTEIN, MOUSE; PLANT EXTRACT; STREPTOZOCIN;

ALLODYNIA; ALLOXAN-INDUCED DIABETES MELLITUS; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DETERMINATION; DRUG EFFECT; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FRACTIONATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPERALGESIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PAIN THRESHOLD; PRIORITY JOURNAL; PRUNELLA; PRUNELLA VULGARIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOUCH; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE RESPONSE; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLORESCENCE; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; NOCICEPTION; PATHOPHYSIOLOGY; PHYTOTHERAPY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION TIME; REVERSED PHASE LIQUID CHROMATOGRAPHY; TIME FACTOR;

ALPHA-AMYLASES; ANALGESICS; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSIDE HYDROLASE INHIBITORS; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INFLORESCENCE; INSULIN; LIPID PEROXIDATION; MALE; MICE; NOCICEPTION; OXIDATIVE STRESS; PAIN THRESHOLD; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PRUNELLA; REACTION TIME; STREPTOZOCIN; TIME FACTORS;

EID: 84992217909     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.09.095     Document Type: Article

References (55)

1. [1] Chiba, Y., Kimbara, Y., Kodera, R., Tsuboi, Y., Sato, K., Tamura, Y., Mori, S., Ito, H., Araki, A., Risk factors associated with falls in elderly patients with type 2 diabetes. J. Diabetes Complicat., 2015.
2. [2] WHO, Global guideline for type 2 diabetes. Diabetes Res. Clin. Pract. 104:1 (2014), 1–52.
3. [3] Kwon, S.S., Kwon, J.-Y., Park, Y.-W., Kim, Y.-H., Lim, J.-B., HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res. Clin. Pract., 2015.
4. [4] Rajanandh, M.G., Kosey, S., Prathiksha, G., Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients – a randomized controlled study. Pharmacol. Rep. 66:1 (2014), 44–48.
5. [5] Arulselvan, P., Subramanian, S.P., Beneficial effects of Murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic beta-cells in experimental diabetes in rats. Chem. Biol. Interact. 165:2 (2007), 155–164.
6. [6] Punitha, I.S., Rajendran, K., Shirwaikar, A., Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. Evid. Based Complement Altern. Med. 2:3 (2005), 375–381.
7. [7] Manonmani, G., Bhavapriya, V., Kalpana, S., Govindasamy, S., Apparanantham, T., Antioxidant activity of Cassia fistula (Linn.) flowers in alloxan induced diabetic rats. J. Ethnopharmacol. 97:1 (2005), 39–42.
8. [8] Al-Azzawie, H.F., Alhamdani, M.S., Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 78:12 (2006), 1371–1377.
9. [9] Kawahito, S., Kitahata, H., Oshita, S., Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J. Gastroenterol. 15:33 (2009), 4137–4142.
10. [10] Sepici-Dincel, A., Acikgoz, S., Cevik, C., Sengelen, M., Yesilada, E., Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J. Ethnopharmacol. 110:3 (2007), 498–503.
11. [11] Raafat, K.M., Omar, A.G., Phytotherapeutic activity of curcumol: isolation, GC–MS identification, and assessing potentials against acute and subchronic hyperglycemia, tactile allodynia, and hyperalgesia. Pharm. Biol., 2015, 1–11.
12. [12] Raafat, K., El-Lakany, A., Acute and subchronic in-vivo effects of Ferula hermonis L. and Sambucus nigra L. and their potential active isolates in a diabetic mouse model of neuropathic pain. BMC Complement. Altern. Med., 15, 2015, 257.
13. [13] Raafat, K., Aboul-Ela, M., El-Lakany, A., Alloxan-induced diabetic thermal hyperalgesia, prophylaxis and phytotherapeutic effects of Rheum ribes L. in mouse model. Arch. Pharm. Res., 2014.
14. [14] Raafat, K., Samy, W., Amelioration of diabetes and painful diabetic neuropathy by Punica granatum L. extract and its spray dried biopolymeric dispersions. Evid. Based Complement Altern. Med., 2014, 2014, 180495.
15. [15] Salvotelli, L., Stoico, V., Perrone, F., Cacciatori, V., Negri, C., Brangani, C., Pichiri, I., Targher, G., Bonora, E., Zoppini, G., Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona Diabetic Foot Screening Program. J. Diabetes Complicat., 2015.
16. [16] Ma, J., Yu, H., Liu, J., Chen, Y., Wang, Q., Xiang, L., Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur. J. Pharmacol. 764 (2015), 599–606.
17. [17] Greig, M., Tesfaye, S., Selvarajah, D., Wilkinson, I.D., Insights into the pathogenesis and treatment of painful diabetic neuropathy. Handb. Clin. Neurol. 126 (2014), 559–578.
18. [18] Cheung, H.Y., Zhang, Q.F., Enhanced analysis of triterpenes, flavonoids and phenolic compounds in Prunella vulgaris L. by capillary zone electrophoresis with the addition of running buffer modifiers. J. Chromatogr. A 1213:2 (2008), 231–238.
19. [19] Fang, X., Chang, R.C., Yuen, W.H., Zee, S.Y., Immune modulatory effects of Prunella vulgaris L. Int. J. Mol. Med. 15:3 (2005), 491–496.
20. [20] Psotova, J., Kolar, M., Sousek, J., Svagera, Z., Vicar, J., Ulrichova, J., Biological activities of Prunella vulgaris extract. Phytother. Res. 17:9 (2003), 1082–1087.
21. [21] Wang, Z.J., Zhao, Y.Y., Chen, Y.Y., Ma, B.N., Triterpenoid compounds of Prunella genus and their features of 13C NMR spectroscopy. Zhongguo Zhong Yao Za Zhi 25:10 (2000), 583–588.
22. [22] Wang, Y., Yin, J., Guo, Q., Xiao, Y., Dynamic change of active component content in different parts of Prunella vulgaris. Zhongguo Zhong Yao Za Zhi 36:6 (2011), 741–745.
23. [23] Raafat, K., Breitinger, U., Mahran, L., Ayoub, N., Breitinger, H.-G., Synergistic inhibition of glycinergic transmission in vitro and in vivo by flavonoids and strychnine. Toxicol. Sci. 118 (2010), 171–182.
24. [24] Zheng, J., He, J., Ji, B., Li, Y., Zhang, X., Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac. J. Clin. Nutr. 16:Suppl. 1 (2007), 427–431.
25. [25] Zhou, Q.X., Liu, F., Zhang, J.S., Lu, J.G., Gu, Z.L., Gu, G.X., Effects of triterpenic acid from Prunella vulgaris L. on glycemia and pancreas in rat model of streptozotozin diabetes. Chin. Med. J. (Engl.) 126:9 (2013), 1647–1653.
26. [26] Cheng, Q., Zhang, X., Wang, O., Liu, J., Cai, S., Wang, R., Zhou, F., Ji, B., Anti-diabetic effects of the ethanol extract of a functional formula diet in mice fed with a fructose/fat-rich combination diet. J. Sci. Food Agric. 95:2 (2015), 401–408.
27. [27] Perera, P.K., Li, Y., Functional herbal food ingredients used in type 2 diabetes mellitus. Pharmacogn. Rev. 6:11 (2012), 37–45.
28. [28] Kwon, Y.I., Apostolidis, E., Shetty, K., In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour. Technol. 99:8 (2008), 2981–2988.
29. [29] Abo, K.A., Fred-Jaiyesimi, A.A., Jaiyesimi, A.E., Ethnobotanical studies of medicinal plants used in the management of diabetes mellitus in South Western Nigeria. J. Ethnopharmacol. 115:1 (2008), 67–71.
30. [30] Shim, Y.J., Doo, H.K., Ahn, S.Y., Kim, Y.S., Seong, J.K., Park, I.S., Min, B.H., Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J. Ethnopharmacol. 85:2–3 (2003), 283–287.
31. [31] Hieke, M., Ness, J., Steri, R., Greiner, C., Werz, O., Schubert-Zsilavecz, M., Weggen, S., Zettl, H., SAR studies of acidic dual gamma-secretase/PPARgamma modulators. Bioorg. Med. Chem. 19:18 (2011), 5372–5382.
32. [32] Sahin, S., Demir, C., Malyer, H., Determination of phenolic compounds in Prunella L. by liquid chromatography-diode array detection. J. Pharm. Biomed. Anal. 55:5 (2011), 1227–1230.
33. [33] Raafat, K.M., Jassar, H., Aboul-Ela, M., El-Lakany, A., Protective effects of Origanum majorana L. against neurodegeneration: fingerprinting, isolation and in vivo glycine receptors behavioral model. Int. J. Phytomed. 5:1 (2013), 46–57.
34. [34] Zhang, W., Welihinda, A., Mechanic, J., Ding, H., Zhu, L., Lu, Y., Deng, Z., Sheng, Z., Lv, B., Chen, Y., Roberge, J.Y., Seed, B., Wang, Y.-X., EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats. Pharmacol. Res. 63:4 (2011), 284–293.
35. [35] Breitinger, U., Raafat, K.M., Breitinger, H.G., Glucose is a positive modulator for the activation of human recombinant glycine receptors. J. Neurochem., 2015.
36. [36] Yasmineh, W.G., Kaur, T.P., Blazar, B.R., Theologides, A., Serum catalase as marker of graft-vs-host disease in allogeneic bone marrow transplant recipients: pilot study. Clin. Chem. 41:11 (1995), 1574–1580.
37. [37] Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed. Chromatogr. 20:9 (2006), 898–903.
38. [38] Ulugol, A., Oltulu, C., Gunduz, O., Citak, C., Carrara, R., Shaqaqi, M.R., Sanchez, A.M., Dogrul, A., 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. Pharmacol. Biochem. Behav. 102:2 (2012), 344–348.
39. [39] Smits, H., Ultenius, C., Deumens, R., Koopmans, G.C., Honig, W.M.M., van Kleef, M., Linderoth, B., Joosten, E.A.J., Effect of spinal cord stimulation in an animal model of neuropathic pain relates to degree of tactile allodynia. Neuroscience 143:2 (2006), 541–546.
40. [40] Fox, A., Gentry, C., Patel, S., Kesingland, A., Bevan, S., Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 105:1–2 (2003), 355–362.
41. [41] Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:2 (1979), 351–358.
42. [42] Wagner, H., Ulrich-Merzenich, G., Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16:2–3 (2009), 97–110.
43. [43] Jaiswal, M., Martin, C.L., Brown, M.B., Callaghan, B., Albers, J.W., Feldman, E.L., Pop-Busui, R., Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J. Diabetes Complicat., 2015.
44. [44] Galeotti, N., Maidecchi, A., Mattoli, L., Burico, M., Ghelardini, C., St John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes. Fitoterapia 92 (2014), 23–33.
45. [45] Wong, M.C., Chung, J.W., Wong, T.K., Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ, 335(7610), 2007, 87.
46. [46] Boulton, A.J., Pharmacologic management of painful diabetic neuropathy. Curr. Diabetes Rep. 8:6 (2008), 429–430.
47. [47] Lindsay, T.J., Rodgers, B.C., Savath, V., Hettinger, K., Treating diabetic peripheral neuropathic pain. Am. Fam. Phys. 82:2 (2010), 151–158.
48. [48] Matsui, T., Tanaka, T., Tamura, S., Toshima, A., Tamaya, K., Miyata, Y., Tanaka, K., Matsumoto, K., alpha-Glucosidase inhibitory profile of catechins and theaflavins. J. Agric. Food Chem. 55:1 (2007), 99–105.
49. [49] Ranilla, L.G., Kwon, Y.I., Apostolidis, E., Shetty, K., Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 101:12 (2010), 4676–4689.
50. [50] Gul, H., Yildiz, O., Dogrul, A., Yesilyurt, O., Isimer, A., The interaction between IL-1β and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 89:1 (2000), 39–45.
51. [51] Paro, M., Italiano, G., Travagli, R.A., Petrelli, L., Zanoni, R., Prosdocimi, M., Fiori, M.G., Cystometric changes in alloxan diabetic rats: evidence for functional and structural correlates of diabetic autonomic neuropathy. J. Auton. Nerv. Syst. 30:1 (1990), 1–11.
52. [52] Calcutt, N.A., Chaplan, S.R., Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122:7 (1997), 1478–1482.
53. [53] Sullivan, K.A., Hayes, J.M., Wiggin, T.D., Backus, C., Su Oh, S., Lentz, S.I., Brosius, F. 3rd, Feldman, E.L., Mouse models of diabetic neuropathy. Neurobiol. Dis. 28:3 (2007), 276–285.
54. [54] Hibatallah, J., Carduner, C., Poelman, M.C., In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J. Pharm. Pharmacol. 51:12 (1999), 1435–1440.
55. [55] Shi, C., Liu, J., Wu, F., Yew, D.T., Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. Int. J. Mol. Sci. 11:1 (2010), 107–123.